🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great kickoff to #GU25: further validation of the PORTOS score from George Zhao - genomic predictor of response to RT for #prostatecancer, part of Decipher by Veracyte GRID report.

It was an honor to have silke gillessen join our GU SDG team Sylvester Comprehensive Cancer Center last week. We had great discussions before #GU25 Thank you so much for visiting us, Silke.

Predicting Dose-Response to Prostate Cancer Radiotherapy: Validation of a Radiation Signature in the Randomized Phase III NRG/RTOG 0126 and SAKK 09/10 Trials - Annals of Oncology annalsofoncology.org/article/S0923-…

x.com/i/article/1890…

Congrats on this important work! Elai Davicioni From our early work to predict DM in IGRT treated patients to now predicting RT dose response - We may have a biomarker for #precisionradiotherapy in #prostatecancer! Alan Dal Pra, MD Alejandro (Ale) Berlin Shankar Siva

#PORTOS biomarker guides radiation dose escalation in #ProstateCancer treatment. George Zhao, MD UW School of Medicine and Public Health & Alan Dal Pra, MD Sylvester Comprehensive Cancer Center join Alicia Morgans, MD, MPH Dana-Farber to discuss updates to the PORTOS trial and how it predicts radiation benefit in #PCa. #WatchNow >

Thanks UroToday.com for highlighting this great work by George Zhao, Phuoc Tran, James Proudfoot, Elai Davicioni Daniel E Spratt William A Hall, MD Jeff Michalski and all team. Incredible collaboration between NRG Oncology SAKK Decipher by Veracyte in the search for more tailored radiation treatments. Full

Please save the Department of Defense 🇺🇸 Prostate Cancer Research Program! We need continued funding to keep fighting #ProstateCancer Senator Alex Padilla Adam Schiff Rep. Mike Levin UroToday.com PCF Science Howard Soule Andrea Miyahira Uromigos

Pleased to share our new article in ASTRO #PracticalRO We focus on scenarios where there is a paucity of data on use of PSMA in clinical decision making, and summarize our recs Great to collaborate with Alan Dal Pra, MD Vedang Murthy Sophia Kamran, MD! practicalradonc.org/article/S1879-…

The role of PSMA PET imaging - Nat Lester-Coll (Nat Lester-Coll, MD) ASTRO Alan Dal Pra, MD Vedang Murthy Sophia Kamran, MD oncodaily.com/science/psma-2… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ProstateCancer #PSMA #PETimaging

Very high inter-reader variability is the achilles heel of #prostateMRI What if #prostateMRI could be like a lab test that gives a quantitative value indicating risk of #ProstateCancer? New 📜 Journal of Urology 🧵1/x Amer. Urol. Assn. European Association of Urology (EAU) UroToday.com PCF Science

Thanks Sophia Kamran, MD & Constantinos Zamboglou for this invitation to highlight keypoints and thoughts about ADT and Post-op RT. sciencedirect.com/science/articl… ✨✨✨✨✨✨✨✨✨✨

Paul Sargos ; Vérane Achard ; Alan Dal Pra, MD ; Abhishek Solanki ; Dr. Jason Efstathiou ; Krishnan Patel, MD, MHS ; Ravi A Madan M.D. ; Deborah Citrin 9/n

1️⃣ Elective Regional Nodal Irradiation in Prostate Cancer 👥 With Dr Srinivas Chilukuri, Mutlay Sayan, MD & Alan Dal Pra, MD 🎯 We cover rationale, patient selection & key trials shaping WPRT in high-risk, SBRT and post op settings. Read 📖 doi.org/10.1016/j.semr…

New data from Denmark suggest improved survival with salvage radiotherapy in the PSMA PET/CT era. jnm.snmjournals.org/content/early/… SNMMI 📊The retrospective analysis excludes patients ineligible for RT based on PSMA PET/CT 💡Randomized data is ideal but challenging in 2025 with

What comes after disease progression in advanced prostate cancer? The best treatment plan depends on your cancer's traits, your health, and personal preferences. Dr. Alan Dal Pra (Alan Dal Pra, MD) of Sylvester Comprehensive Cancer Center, explains how your risk group helps guide next steps.

Excited to share our newest paper on digital pathology AI biomarkers in prostate cancer RT. In this work we: ▶️performed a systematic review ▶️checked ongoing trials ▶️collected an expert consensus sciencedirect.com/science/articl… Thanks Radiotherapy & Oncology for accepting this work

Innovation & Insights Session from NRG Oncology Trials➡️ #radonc ☢️ 🧹🧹🧹🧹 #notsurprised #innovators Congrats to all the presenters on their cutting edge work! David Qian, MD, PhD Alan Dal Pra, MD Quynh Thu Le Stanford Radiation Oncology Dr. Nguyen Dr. Mayadev UC San Diego Rad Med RTOG Foundation

Eva Compérat is all in for #RENALC25, #BLADDR25 and #PROSCA25 - here's why you should be too! ➡️Register now to secure your spot: tinyurl.com/yc6hvsbw 👥Highly interactive 🧑‍⚕️Outstanding, approachable faculty 🌟"One of the best meetings that exist" OncoAlert Badrinath Konety, MD, MBA

Seminars in Radiation Oncology Elsevier is pleased to share "Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer" by Dr. Vérane Achard, Dr. Dal Pra Alan Dal Pra, MD, Dr. Sargos Paul Sargos sciencedirect.com/science/articl…